ScholarWorks@Korea University: Sa, Jason K.

Detailed Information

Sa, Jason K. (사경하)

Graduate School (Department of Biomedical Sciences)

Research Area

Tel 02-2286-1468
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Gastric cancer:2||Pharmacogenomics:2||Glioblastoma:2||biomarker:2||glioblastoma:2||RNF11:1||brain perivascular tumor microenvironment:1||GCG:1||FGF21:1||Patientderived xenograft:1||Proteomics:1||highthroughput drug screening:1||PARP inhibitor:1||Biomarkers:1||nextgeneration sequencing:1||immune response:1||multispecific:1||platform:1||cMet:1||Multiomics:1||genomics:1||cancer genome:1||olaparib:1||Intratumoral heterogeneity:1||Epithelial ovarian cancer:1||Ramucirumab:1||Pharmacogenomic analysis:1||Next generation sequencing:1||Genetic stability:1||Carcinoma:1||personalized medicine:1||Alzheimer's disease:1||chronic inflammation:1||Ulipristal acetate (UPA):1||STAT3/CCL2:1||Angiogenesis signature:1||ethnic:1||Gefitinib:1||twodrug combination:1||microfluidic coculture chip:1||dexamethasone:1||Machine learning:1||complex disease:1||IL1RA:1||Uterine leiomyosarcoma:1||Selective progesterone receptor modulators:1||AZD4547:1||TCGA molecular subtype:1||radiogenomics:1||PIK3CAE542K:1||tumor heterogeneity:1||patientderived tumor cell:1||TP53 mutations:1||ID2:1||Tumorigenicity:1||Longterm culture:1||immunosuppressant:1||radiomics:1||tumor purity:1||Gynecologic malignancy:1||Tumor:1||epithelial ovarian carcinoma:1||Patientderived xenograft model (PDX):1||Sexdifference:1||genetics:1||Adult human multipotent neural cells:1||Hepatocellular:1||Pembrolizumab:1||cerebral metastatic lung cancer cells:1||tofacitinib:1||Temozolomide:1||Cancer genomics:1||conjugation:1||NASH:1||GLP1:1||FGF19:1||FGFR4:1||immune checkpoint inhibitor:1||tumor mutation burden  TMB:1||

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE